Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Elanco's shares opened at $32.25 each on the firm's New York Stock Exchange (NYSE) debut.
Norwegian company Planktonic is increasing production of its cryopreserved live feed for the aquaculture sector.
Indian company Ashish Life Science has gained EU Good Manufacturing Practice (GMP) accreditation for a manufacturing site in Tarapur.
Elanco has revealed the pricing of its initial public offering (IPO) of 62.9 million shares of common stock.
US contract development and manufacturing organization (CDMO) Tropichem Research Labs is building a non-sterile liquid facility in Montreal.
The head of AquaBounty Technologies claims Canadian customers are very pleased with the company's genetically engineered (GE) salmon and says he hopes to begin producing the fish at a US facility by the end of the year.
UK firm Animalcare has seen its shares slowly begin to recover since the divestment of its wholesale division.
Irish veterinary generics specialist Chanelle has opened a new €10 million ($11.6 million) manufacturing facility at its headquarters in Loughrea, Galway.
Halfway through 2018, three of the leading animal health players have made great strides in terms of top-line growth. Others have fallen foul of currency exchange issues. Animal Pharm editor Joseph Harvey looks out how the first six months panned out for the top 10.
Phibro Animal Health has recently seen the value of its shares reach a record high.
Contract research organization Cyton Biosciences has opened its first office outside the UK in Mannheim, Germany, in order to guarantee its full array of services in the EU post-Brexit.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.